Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy

Proc Natl Acad Sci U S A. 2000 May 9;97(10):5393-8. doi: 10.1073/pnas.97.10.5393.

Abstract

The long-term kinetics of T cell production following highly active antiretroviral therapy (HAART) were investigated in blood and lymph node in a group of HIV-infected subjects at early stage of established infection and prospectively studied for 72 wk. Before HAART, CD4 and CD8 T cell turnover was increased. However, the total number of proliferating CD4(+) T lymphocytes, i.e., CD4(+)Ki67(+) T lymphocytes, was not significantly different in HIV-infected (n = 73) and HIV-negative (n = 15) subjects, whereas proliferating CD8(+)Ki67(+) T lymphocytes were significantly higher in HIV-infected subjects. After HAART, the total body number of proliferating CD4(+)Ki67(+) T lymphocytes increased over time and was associated with an increase of both naive and memory CD4(+) T cells. The maximal increase (2-fold) was observed at week 36, whereas at week 72 the number of proliferating CD4(+) T cells dropped to baseline levels, i.e., before HAART. The kinetics of the fraction of proliferating CD4 and CD8 T cells were significantly correlated with the changes in the total body number of these T cell subsets. These results demonstrate a direct relationship between ex vivo measures of T cell production and quantitative changes in total body T lymphocyte populations. This study provides advances in the delineation of the kinetics of T cell production in HIV infection in the presence and/or in the absence of HAART.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Dideoxynucleosides / therapeutic use
  • Drug Therapy, Combination
  • HIV Infections / blood
  • HIV Infections / drug therapy*
  • HIV Infections / immunology*
  • HIV Seronegativity / immunology*
  • Humans
  • Kinetics
  • Lymph Nodes / immunology
  • Lymphocyte Activation*
  • Middle Aged
  • Nelfinavir / therapeutic use
  • Regression Analysis
  • Saquinavir / therapeutic use
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocytes / immunology*
  • Time Factors

Substances

  • Anti-HIV Agents
  • Dideoxynucleosides
  • Nelfinavir
  • Saquinavir
  • abacavir